Abstract | OBJECTIVES: DESIGN: RESULTS:
Progesterone did not elicit any proliferative effect on MCF-7/PGRMC1-3HA cells. By contrast, P4-BSA-FITC, DRSP, MPA and NET significantly triggered proliferation of MCF-7/PGRMC1-3HA cells, the effect being more pronounced for NET. Almost no effect of progestogens on proliferation was observed in MCF-7 cells. In MCF-7/PGRMC1-3HA cells, expression of Erk1/2 was significantly reduced by 40% compared to MCF-7 cells. CONCLUSIONS: Our data indicate that PGRMC1 mediates a progestogen-dependent proliferative signal in MCF-7 cells. Of significant interest is that progesterone and synthetic progestins that are used for hormone therapy are different in their proliferative effects on MCF-7 and MCF-7/PGRMC1-3HA cells. Progesterone appears to act neutrally, whereas MPA, NET and DRSP trigger proliferation and thus might increase breast cancer risk. The data presented are very important in terms of the positive results of progestogens and breast cancer risk in clinical studies so far.
|
Authors | Hans Neubauer, Rong Chen, Helen Schneck, Thomas Knorrp, Markus F Templin, Tanja Fehm, Michael A Cahill, Harald Seeger, Qi Yu, Alfred O Mueck |
Journal | Hormone molecular biology and clinical investigation
(Horm Mol Biol Clin Investig)
Vol. 6
Issue 1
Pg. 185-92
(Apr 01 2011)
ISSN: 1868-1883 [Print] Germany |
PMID | 25961254
(Publication Type: Journal Article)
|